vs
ACNB CORP（ACNB）与RIGEL PHARMACEUTICALS INC（RIGL）财务数据对比。点击上方公司名可切换其他公司
RIGEL PHARMACEUTICALS INC的季度营收约是ACNB CORP的1.5倍（$69.8M vs $47.2M），RIGEL PHARMACEUTICALS INC净利率更高（384.0% vs 22.9%，领先361.1%），ACNB CORP同比增速更快（42.2% vs 21.2%），过去两年RIGEL PHARMACEUTICALS INC的营收复合增速更高（53.7% vs 22.1%）
ACNB集团是总部位于美国宾夕法尼亚州的金融控股公司，提供零售及商业银行服务、财富管理、信托服务、财产及意外伤害保险等金融产品，主要服务宾夕法尼亚州中南部、马里兰州北部的当地居民及中小企业客户。
Rigel制药是一家临床阶段生物技术企业，专注于研发及商业化针对自身免疫性疾病、炎症性疾病与血液疾病的靶向小分子疗法，核心市场位于美国，旗下已获批产品可治疗成人免疫性血小板减少症，致力于满足未被覆盖的临床医疗需求。
ACNB vs RIGL — 直观对比
营收规模更大
RIGL
是对方的1.5倍
$47.2M
营收增速更快
ACNB
高出21.0%
21.2%
净利率更高
RIGL
高出361.1%
22.9%
两年增速更快
RIGL
近两年复合增速
22.1%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $47.2M | $69.8M |
| 净利润 | $10.8M | $268.1M |
| 毛利率 | — | 91.5% |
| 营业利润率 | 27.9% | 33.2% |
| 净利率 | 22.9% | 384.0% |
| 营收同比 | 42.2% | 21.2% |
| 净利润同比 | 63.8% | 1769.2% |
| 每股收益（稀释后） | $1.10 | $14.11 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ACNBRIGL
| Q4 25 | $47.2M | $69.8M | ||
| Q3 25 | $50.9M | $69.5M | ||
| Q2 25 | $50.3M | $101.7M | ||
| Q1 25 | $43.5M | $53.3M | ||
| Q4 24 | $33.2M | $57.6M | ||
| Q3 24 | $34.1M | $55.3M | ||
| Q2 24 | $33.3M | $36.8M | ||
| Q1 24 | $31.6M | $29.5M |
净利润ACNBRIGL
| Q4 25 | $10.8M | $268.1M | ||
| Q3 25 | $14.9M | $27.9M | ||
| Q2 25 | $11.6M | $59.6M | ||
| Q1 25 | $-272.0K | $11.4M | ||
| Q4 24 | $6.6M | $14.3M | ||
| Q3 24 | $7.2M | $12.4M | ||
| Q2 24 | $11.3M | $-1.0M | ||
| Q1 24 | $6.8M | $-8.2M |
毛利率ACNBRIGL
| Q4 25 | — | 91.5% | ||
| Q3 25 | — | 93.2% | ||
| Q2 25 | — | 95.6% | ||
| Q1 25 | — | 91.7% | ||
| Q4 24 | — | 89.9% | ||
| Q3 24 | — | 85.5% | ||
| Q2 24 | — | 92.4% | ||
| Q1 24 | — | 93.1% |
营业利润率ACNBRIGL
| Q4 25 | 27.9% | 33.2% | ||
| Q3 25 | 37.2% | 40.9% | ||
| Q2 25 | 29.7% | 60.1% | ||
| Q1 25 | -1.3% | 23.9% | ||
| Q4 24 | 24.8% | 28.9% | ||
| Q3 24 | 27.6% | 25.4% | ||
| Q2 24 | 42.8% | 1.2% | ||
| Q1 24 | 26.9% | -23.6% |
净利率ACNBRIGL
| Q4 25 | 22.9% | 384.0% | ||
| Q3 25 | 29.2% | 40.2% | ||
| Q2 25 | 23.2% | 58.6% | ||
| Q1 25 | -0.6% | 21.5% | ||
| Q4 24 | 19.9% | 24.9% | ||
| Q3 24 | 21.1% | 22.5% | ||
| Q2 24 | 33.9% | -2.8% | ||
| Q1 24 | 21.4% | -27.9% |
每股收益（稀释后）ACNBRIGL
| Q4 25 | $1.10 | $14.11 | ||
| Q3 25 | $1.42 | $1.46 | ||
| Q2 25 | $1.11 | $3.28 | ||
| Q1 25 | $-0.03 | $0.63 | ||
| Q4 24 | $0.77 | $0.82 | ||
| Q3 24 | $0.84 | $0.70 | ||
| Q2 24 | $1.32 | $-0.06 | ||
| Q1 24 | $0.80 | $-0.47 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $65.6M | $155.0M |
| 总债务越低越好 | $255.4M | $52.5M |
| 股东权益账面价值 | $420.0M | $391.5M |
| 总资产 | $3.2B | $513.6M |
| 负债/权益比越低杠杆越低 | 0.61× | 0.13× |
8季度趋势，按日历期对齐
现金及短期投资ACNBRIGL
| Q4 25 | $65.6M | $155.0M | ||
| Q3 25 | $102.1M | $137.1M | ||
| Q2 25 | $103.1M | $108.4M | ||
| Q1 25 | $123.6M | $77.1M | ||
| Q4 24 | $47.3M | $77.3M | ||
| Q3 24 | $58.1M | $61.1M | ||
| Q2 24 | $86.3M | $49.1M | ||
| Q1 24 | $53.1M | $49.5M |
总债务ACNBRIGL
| Q4 25 | $255.4M | $52.5M | ||
| Q3 25 | $255.4M | $60.0M | ||
| Q2 25 | $255.4M | $60.0M | ||
| Q1 25 | $255.3M | $60.0M | ||
| Q4 24 | $255.3M | $60.0M | ||
| Q3 24 | $255.3M | $60.0M | ||
| Q2 24 | $255.3M | $60.0M | ||
| Q1 24 | $255.3M | $60.0M |
股东权益ACNBRIGL
| Q4 25 | $420.0M | $391.5M | ||
| Q3 25 | $408.6M | $117.6M | ||
| Q2 25 | $395.2M | $81.9M | ||
| Q1 25 | $386.9M | $18.6M | ||
| Q4 24 | $303.3M | $3.3M | ||
| Q3 24 | $306.8M | $-14.6M | ||
| Q2 24 | $289.3M | $-29.9M | ||
| Q1 24 | $279.9M | $-31.7M |
总资产ACNBRIGL
| Q4 25 | $3.2B | $513.6M | ||
| Q3 25 | $3.3B | $242.5M | ||
| Q2 25 | $3.3B | $206.7M | ||
| Q1 25 | $3.3B | $176.0M | ||
| Q4 24 | $2.4B | $164.0M | ||
| Q3 24 | $2.4B | $139.4M | ||
| Q2 24 | $2.5B | $128.4M | ||
| Q1 24 | $2.4B | $126.5M |
负债/权益比ACNBRIGL
| Q4 25 | 0.61× | 0.13× | ||
| Q3 25 | 0.62× | 0.51× | ||
| Q2 25 | 0.65× | 0.73× | ||
| Q1 25 | 0.66× | 3.23× | ||
| Q4 24 | 0.84× | 18.25× | ||
| Q3 24 | 0.83× | — | ||
| Q2 24 | 0.88× | — | ||
| Q1 24 | 0.91× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $53.6M | $22.0M |
| 自由现金流经营现金流 - 资本支出 | $52.6M | — |
| 自由现金流率自由现金流/营收 | 111.4% | — |
| 资本支出强度资本支出/营收 | 2.3% | — |
| 现金转化率经营现金流/净利润 | 4.96× | 0.08× |
| 过去12个月自由现金流最近4个季度 | $92.2M | — |
8季度趋势，按日历期对齐
经营现金流ACNBRIGL
| Q4 25 | $53.6M | $22.0M | ||
| Q3 25 | $23.2M | $24.0M | ||
| Q2 25 | $17.8M | $30.5M | ||
| Q1 25 | $-71.0K | $-893.0K | ||
| Q4 24 | $39.8M | $14.5M | ||
| Q3 24 | $13.6M | $21.7M | ||
| Q2 24 | $9.7M | $302.0K | ||
| Q1 24 | $10.8M | $-5.0M |
自由现金流ACNBRIGL
| Q4 25 | $52.6M | — | ||
| Q3 25 | $22.8M | — | ||
| Q2 25 | $17.6M | — | ||
| Q1 25 | $-730.0K | — | ||
| Q4 24 | $38.8M | — | ||
| Q3 24 | $13.3M | — | ||
| Q2 24 | $9.4M | — | ||
| Q1 24 | $10.7M | — |
自由现金流率ACNBRIGL
| Q4 25 | 111.4% | — | ||
| Q3 25 | 44.7% | — | ||
| Q2 25 | 35.0% | — | ||
| Q1 25 | -1.7% | — | ||
| Q4 24 | 117.0% | — | ||
| Q3 24 | 39.1% | — | ||
| Q2 24 | 28.3% | — | ||
| Q1 24 | 33.9% | — |
资本支出强度ACNBRIGL
| Q4 25 | 2.3% | — | ||
| Q3 25 | 0.8% | — | ||
| Q2 25 | 0.4% | — | ||
| Q1 25 | 1.5% | — | ||
| Q4 24 | 2.9% | — | ||
| Q3 24 | 0.7% | — | ||
| Q2 24 | 0.9% | — | ||
| Q1 24 | 0.2% | — |
现金转化率ACNBRIGL
| Q4 25 | 4.96× | 0.08× | ||
| Q3 25 | 1.56× | 0.86× | ||
| Q2 25 | 1.52× | 0.51× | ||
| Q1 25 | — | -0.08× | ||
| Q4 24 | 6.03× | 1.01× | ||
| Q3 24 | 1.88× | 1.75× | ||
| Q2 24 | 0.86× | — | ||
| Q1 24 | 1.60× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
